Home Medical Devices global-pcr-based-transplant-diagnostics-market

Medical Devices

Image

Global PCR Based Transplant Diagnostics Market – Industry Trends and Forecast to 2031

  • Medical Devices
  • Published Report
  • Mar 2024
  • Global
  • 350 Pages
  • No of Tables: 216
  • No of Figures: 36

Global PCR Based Transplant Diagnostics Market, By Test Type (CMV PCR Test, EBV PCR Test, BKV PCR Test, VZV PCR Test, HSV1 PCR Test, HSV2 PCR Test, Parvovirus B19 PCR Test, P. Jirovecii PCR Test, JCV PCR Test, Adenovirus PCR Test, and Aspergillus Spp PCR Test), Transplant Type (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, and Other Transplantations), Application (Diagnostic Applications and Research Applications), End User (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories, and Academic Institutes) - Industry Trends and Forecast to 2031.

PCR Based Transplant Diagnostics Market

PCR Based Transplant Diagnostics Market Analysis and Insights

One of the primary factors driving the growth of the market is the rising prevalence of organ failure. In addition, the rising popularity of non-invasive diagnostic methods across the globe is another key driver for market growth. Advancements in organ preservative techniques also influence the market. However, the shortage of professionals with expertise in transplant diagnostics is restraining the market growth.

On the other hand, strategic initiation and technology launches by the market players act as an opportunity for market growth. However, ethical challenges faced during organ transplantation may create a challenge to market growth.

PCR Based Transplant Diagnostics MarketPC​​​​​​​R Based Transplant Diagnostics Market

Data Bridge Market Research analyses that the market is expected to reach USD 995,007.52 thousand by 2031, from USD 612,500.00 thousand in 2023, growing with a CAGR of 6.5% in the forecast period of 2024 to 2031.

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Thousand

Segments Covered

Test Type (CMV PCR Test, EBV PCR Test, BKV PCR Test, VZV PCR Test, HSV1 PCR Test, HSV2 PCR Test, Parvovirus B19 PCR Test, P. Jirovecii PCR Test, JCV PCR Test, Adenovirus PCR Test, and Aspergillus Spp PCR Test), Transplant Type (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, and Other Transplantations), Application (Diagnostic Applications and Research Applications), End User (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories, and Academic Institutes)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa

Market Players Covered

Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Eurofins Viracor, LLC, Sonic Healthcare USA, Ambar Lab, ARUP Laboratories, and Dr. Lal PathLabs among others

Market Definition

PCR is a molecular biology technique used to amplify specific DNA sequences, enabling the detection and analysis of genetic material with high precision and sensitivity. In the context of transplant diagnostics, PCR-based assays are employed to assess compatibility between organ donors and recipients, monitor post-transplant outcomes, and detect signs of rejection or complications. The market can be defined as the segment of the healthcare industry that focuses on utilizing PCR technology for diagnostic purposes in organ transplantation procedures.

Global PCR Based Transplant Diagnostics Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Increasing Prevalence of Organ Failure

There is a growing demand for organ transplants to save lives and improve the quality of life for affected individuals, as the incidence of organ failure continues to rise. Organs such as kidney, liver, heart, and lungs may fail due to various reasons, including chronic diseases, genetic disorders, or trauma. The growing prevalence of chronic diseases, such as chronic kidney disease, liver disease, and heart disease, contributes to an expanding patient pool in need of organ transplants. These patients often require transplant diagnostics to ensure compatibility between the donor organ and the recipient, minimizing the risk of rejection. Hence, the increasing prevalence of organ failure is driving the market growth.

  • Rising Popularity of Non-Invasive Diagnostic Methods

Non-invasive diagnostic methods, such as blood tests and imaging techniques, eliminate the need for invasive procedures such as tissue biopsies. This results in increased patient comfort, leading to higher acceptance and compliance with diagnostic assessments. In the context of transplant diagnostics, non-invasive methods offer a less intrusive way to assess compatibility between donors and recipients. Invasive diagnostic procedures, such as tissue biopsies, carry inherent risks of complications, including bleeding and infection. Non-invasive methods, being less risky, appeal to both patients and healthcare providers. The reduction in the risk of complications is particularly significant in the context of transplant patients who may already be immuno-compromised. Hence, the rising popularity of non-invasive diagnostic methods is driving the market growth.

PC​​​​​​​R Based Transplant Diagnostics Market

Opportunity

  • Strategic Initiation and Technology Launches by Market Players

The escalating growth in the PCR based transplant diagnostics market, driven by the increased demand for donor organs, emphasizes the strategic initiatives such as partnerships, business expansions, and developmental endeavors. These initiatives, guided by well-thought-out strategies, include the introduction of transplant diagnostic kits, such as the Aspergillus Spp PCR Test, PCR Test, CMV PCR Test, EBV PCR Test, BKV PCR Test, and VZV PCR Test. Implementing these strategic frameworks enables market participants to harmonize with their organizational activities, enhancing operational efficiency and aligning efforts with the dynamic landscape of transplant diagnostics.

Hence, these strategic initiatives by the market players may be expected to act as an opportunity for market growth.

Restraints/Challenges

  • Shortage of Professionals with Expertise in Transplant Diagnostics

Shortage of skilled professionals may result in limited accessibility to specialized transplant diagnostic services. This could be particularly challenging for healthcare facilities in regions with a scarcity of trained personnel, leading to delayed or inadequate diagnostic support for organ transplant procedures. The shortage of experts in transplant diagnostics may compromise the quality and accuracy of diagnostic assessments. Lack of specialized knowledge and experience could result in errors in interpreting test results, potentially impacting the success rates of organ transplantation.

This may also impact research and development efforts in transplant diagnostics. Insufficient expertise may slow down the pace of innovation, hindering the development of new diagnostic technologies and approaches, which is restraining the market growth

  • Ethical Challenges Faced During Organ Transplantation

The escalating incidence of vital organ failures, coupled with an insufficient supply, has created a pronounced gap between the growing demand for organs and their limited availability. This critical issue has not only prolonged approval times for organ recipients but has also contributed to a rise in fatalities. In addressing this pressing challenge, PCR-based diagnostic tests play a pivotal role, helping ensure the compatibility and viability of organs for transplantation. Tests such as the HLA Typing PCR Test and Cytomegalovirus (CMV) PCR Test are instrumental in determining the compatibility between donors and recipients, aiding in efficient organ allocation and reducing approval times.

It is therefore apparent that ethical challenges faced during organ transplantation are expected to challenge market growth.

Recent Developments

  • In January 2024, Laboratory Corporation of America Holdings launched a new test for preeclampsia in pregnant women which represents a significant advancement in maternal healthcare. This advanced diagnostic tools, healthcare providers can identify women at higher risk of severe preeclampsia earlier in their pregnancies. This allows the company for more vigilant monitoring and proactive medical intervention, potentially reducing the risk of complications and improving maternal and fetal outcomes
  • In September 2023, Sonic Healthcare's acquired Healius Ltd., to provide development in the Australian healthcare landscape. This acquisition further solidifies Sonic's position as a global leader in pathology, strengthening its competitive edge against other international players. It signifies the company's commitment to expansion and consolidation within the industry, potentially paving the way for similar mergers in other regions
  • In October 2023, Sonic Healthcare's invested in PaigeAI, an AI-powered pathology company, underscores their commitment to harnessing cutting-edge technology for improved diagnostic accuracy and efficiency in the field of pathology. This move holds significant implications for the future of medical diagnostics. This precision approach can lead to more effective treatments and potentially reduce the risk of side effects from unnecessary medications
  • In August 2020, Eurofins Viracor collaborated with the Northwestern University Comprehensive Transplant Center, a leader in solid organ transplantation medicine in North America, through high-impact research and its clinical training programs. This research collaboration has further verified the novel test obtained through Eurofins’ recent acquisition of Transplant Genomics Inc. (“TGI”) and its blood gene expression test, TruGraf. TruGraf can rule out “silent” subclinical kidney rejection in kidney transplant patients with stable kidney function. TGI has recently received a draft Local Coverage Determination (LCD) decision from the Centers for Medicare & Medicaid Services (CMS) via Palmetto GBA’s Molecular Diagnostic Services (MolDX) Program. This has helped the company to validate its research
  • In June 2020, Transplant Genomics, Inc. and Eurofins Viracor announced the development of the Eurofins Transplant Medical and Scientific Advisory Board, engaging diverse expertise and understanding in transplantation and technology development to improve the clinical value of diagnostics throughout the transplant community. Board associates are focusing on improvement and product development, utilizing their unique perspectives to help TGI and Viracor expand to serve the unmet needs in transplantation and guide future products. This has helped the company to expand its product portfolio

Global PCR Based Transplant Diagnostics Market Scope

The global PCR based transplant diagnostics market is categorized into four notable segments based on test type, transplant type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

Test Type

  • CMV PCR Test
  • EBV PCR Test
  • BKV PCR Test
  • VZV PCR Test
  • HSV1 PCR Test
  • HSV2 PCR Test
  • Parvovirus B19 PCR Test
  • P. Jirovecii PCR Test
  • JCV PCR Test
  • Adenovirus PCR Test
  • Aspergillus Spp PCR Test

On the basis of test type, the global PCR based transplant diagnostics market is segmented into CMV PCR test, EBV PCR test, BKV PCR test, VZV PCR test, HSV1 PCR test, HSV2 PCR test, Parvovirus B19 PCR test, P. Jirovecii PCR test, JCV PCR test, Adenovirus PCR test, and Aspergillus Spp PCR test.

Transplant Type

  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Transplantations

On the basis of transplant type, the global PCR based transplant diagnostics market is segmented into kidney transplantation, liver transplantation, heart transplantation, lung transplantation, pancreas transplantation, and other transplantations.

Application

  • Diagnostic Applications
  • Research Applications

On the basis of application, the global PCR based transplant diagnostics market is segmented into diagnostic application, and research applications.

End User

  • Hospitals and Transplant Centers
  • Commercial Service Providers
  • Research Laboratories and Academic Institutes

On the basis of end user, the global PCR based transplant diagnostics market is segmented into hospitals and transplant centers, commercial service providers, and research laboratories and academic institutes.

PC​​​​​​​R Based Transplant Diagnostics Market

Global PCR Based Transplant Diagnostics Market Regional Analysis/Insights

The global PCR based transplant diagnostics market is categorized into four notable segments based on test type, transplant type, application, and end user.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.

North America is expected to dominate the market due to the presence of major market players and increased technological advancement in the region. The U.S. is expected to dominate the North America region due to rising demand for organ transplantation in the country. Germany is expected to dominate Europe region owing to the rising awareness about the application of PCR (Polymerase Chain Reaction) based transplant diagnostics in the country. China is expected to dominate Asia-Pacific region due to rising prevalence of kidney failure across the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

PC​​​​​​​R Based Transplant Diagnostics Market

Global PCR Based Transplant Diagnostics Market Share Analysis and Competitive Landscape

Global PCR based transplant diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, product type lifeline curve. The above data points provided are only related to the company’s focus on the global PCR based transplant diagnostics market.

Some of the major players operating in the market are Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Eurofins Viracor, LLC, Sonic Healthcare USA, Ambar Lab, ARUP Laboratories, and Dr. Lal PathLabs among others.

SKU-

TABLE 1 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 2 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 3 GLOBAL CMV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 4 GLOBAL EBV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 5 GLOBAL BKV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 6 GLOBAL VZV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 7 GLOBAL HSV1 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 8 GLOBAL HSV2 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 9 GLOBAL PARVOVIRUS B19 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 10 GLOBAL P. JIROVECII PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 11 GLOBAL JCV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 12 GLOBAL ADENOVIRUS PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 13 GLOBAL ASPERGILLUS SPP PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 14 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 15 GLOBAL KIDNEY TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 GLOBAL LIVER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 GLOBAL HEART TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 18 GLOBAL LUNG TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 19 GLOBAL PANCREAS TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 20 GLOBAL OTHER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 22 GLOBAL DIAGNOSTIC APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 23 GLOBAL RESEARCH APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 24 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 25 GLOBAL HOSPITALS AND TRANSPLANT CENTERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 26 GLOBAL COMMERCIAL SERVICE PROVIDERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 27 GLOBAL RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 29 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 30 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 31 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 32 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 33 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 34 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 35 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 36 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 37 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 38 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 39 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 40 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 41 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 42 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 43 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 44 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 45 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 46 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 47 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 48 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 49 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 50 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 51 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 52 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 53 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 54 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 55 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 56 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 58 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 60 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 61 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 63 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 64 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 65 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 66 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 67 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 68 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 70 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 71 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 72 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 73 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 74 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 75 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 76 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 77 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 78 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 80 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 81 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 82 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 83 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 85 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 86 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 87 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 88 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 89 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 90 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 91 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 92 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 93 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 94 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 95 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 96 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 97 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 98 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 100 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 101 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 102 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 103 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 104 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 105 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 106 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 107 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 108 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 109 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 110 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 111 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 112 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 113 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 114 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 115 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 116 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 117 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 118 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 119 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 120 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 121 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 122 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 123 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 124 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 125 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 126 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 127 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 128 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 129 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 130 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 131 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 132 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 133 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 134 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 135 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 136 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 137 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 138 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 139 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 140 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 141 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 142 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 143 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 144 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 145 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 146 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 147 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 148 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 149 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 150 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 151 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 152 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 153 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 154 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 155 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 156 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 157 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 158 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 159 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 160 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 161 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 162 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 163 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 164 REST OF ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 165 REST OF ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 166 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 167 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 168 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 169 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 170 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 171 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 172 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 173 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 174 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 175 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 176 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 177 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 178 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 179 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 180 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 181 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 182 REST OF SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 183 REST OF SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 184 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 185 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 186 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 187 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 188 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 189 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 190 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 191 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 192 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 193 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 194 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 195 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 196 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 197 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 198 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 199 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 200 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 201 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 202 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 203 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 204 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 205 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 206 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 207 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 208 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 209 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 210 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 211 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

TABLE 212 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND)

TABLE 213 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 214 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 215 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 216 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The PCR Based Transplant Diagnostics Market size will be worth USD 995,007.52 thousand during the forecast period.
The PCR Based Transplant Diagnostics Market growth rate is 6.5% during the forecast period.
The Increasing Prevalence of Organ Failure and Rising Popularity of Non-Invasive Diagnostic Methods are the growth drivers of the PCR Based Transplant Diagnostics Market.
The test type, transplant type, application, and end user are the factors on which the PCR Based Transplant Diagnostics Market research is based.
The major companies in the PCR Based Transplant Diagnostics Market are Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Eurofins Viracor, LLC, Sonic Healthcare USA, Ambar Lab, ARUP Laboratories, and Dr. Lal PathLabs.

BROWSE RELATED Press Release

The Increasing Prevalence of Organ Failure Drives the Demand for the Global PCR Based Transplant Diagnostics Market Growth
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Buy Now
Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report
Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Image
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Image
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future